ProPhase Labs (PRPH) to Release Quarterly Earnings on Wednesday

ProPhase Labs (NASDAQ:PRPH) is scheduled to announce its earnings results before the market opens on Wednesday, November 13th. Analysts expect the company to announce earnings of ($0.31) per share for the quarter.

ProPhase Labs (NASDAQ:PRPH) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.25). ProPhase Labs had a negative return on equity of 54.04% and a negative net margin of 146.39%. The company had revenue of $2.47 million for the quarter. On average, analysts expect ProPhase Labs to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

ProPhase Labs Stock Up 1.5 %

PRPH opened at $0.75 on Tuesday. The firm has a market cap of $14.31 million, a price-to-earnings ratio of -0.61 and a beta of -0.10. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.44 and a current ratio of 1.58. The firm’s 50-day simple moving average is $2.31 and its 200-day simple moving average is $3.35. ProPhase Labs has a twelve month low of $0.66 and a twelve month high of $7.48.

ProPhase Labs Company Profile

ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.